ABBVIE BIOTECH VENTURES
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
ABBVIE BIOTECH VENTURES
Industry:
Biotechnology Financial Services Venture Capital
Founded:
2013-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Apache COVID-19 Google Optimize 360 Amazon Elastic Load Balancing Sticky Session Amazon ALB SEO_H2 Adobe Experience Manager
Similar Organizations
BlueStone Venture Partners
BlueStone Venture Partners is a life science venture capital fund investing in entrepreneurial companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-06 | AmbAgon Therapeutics | AbbVie Biotech Ventures investment in Series A - AmbAgon Therapeutics | 85 M USD |
| 2021-11-02 | Nitrase Therapeutics | AbbVie Biotech Ventures investment in Series A - Nitrase Therapeutics | 7 M USD |
| 2021-10-26 | Quanta Therapeutics | AbbVie Biotech Ventures investment in Series C - Quanta Therapeutics | 60 M USD |
| 2021-08-18 | Jnana Therapeutics | AbbVie Biotech Ventures investment in Series B - Jnana Therapeutics | 50 M USD |
| 2021-08-17 | Starday Foods | AbbVie Biotech Ventures investment in Seed Round - Starday Foods | 4 M USD |
| 2021-07-15 | Stemson Therapeutics | AbbVie Biotech Ventures investment in Series A - Stemson Therapeutics | 15 M USD |
| 2021-06-14 | Ribon Therapeutics | AbbVie Biotech Ventures investment in Series C - Ribon Therapeutics | 65 M USD |
| 2021-03-03 | Caribou Biosciences | AbbVie Biotech Ventures investment in Series C - Caribou Biosciences | 115 M USD |
| 2021-03-01 | Carisma Therapeutics | AbbVie Biotech Ventures investment in Series B - Carisma Therapeutics | 12 M USD |
| 2021-01-07 | Carisma Therapeutics | AbbVie Biotech Ventures investment in Series B - Carisma Therapeutics | 47 M USD |